231 related articles for article (PubMed ID: 18057930)
1. Improvement of P450(BM-3) whole-cell biocatalysis by integrating heterologous cofactor regeneration combining glucose facilitator and dehydrogenase in E. coli.
Schewe H; Kaup BA; Schrader J
Appl Microbiol Biotechnol; 2008 Feb; 78(1):55-65. PubMed ID: 18057930
[TBL] [Abstract][Full Text] [Related]
2. P450(BM-3)-catalyzed whole-cell biotransformation of alpha-pinene with recombinant Escherichia coli in an aqueous-organic two-phase system.
Schewe H; Holtmann D; Schrader J
Appl Microbiol Biotechnol; 2009 Jul; 83(5):849-57. PubMed ID: 19266193
[TBL] [Abstract][Full Text] [Related]
3. Design of a cytochrome P450BM3 reaction system linked by two-step cofactor regeneration catalyzed by a soluble transhydrogenase and glycerol dehydrogenase.
Mouri T; Shimizu T; Kamiya N; Goto M; Ichinose H
Biotechnol Prog; 2009; 25(5):1372-8. PubMed ID: 19725101
[TBL] [Abstract][Full Text] [Related]
4. High-throughput screens based on NAD(P)H depletion.
Glieder A; Meinhold P
Methods Mol Biol; 2003; 230():157-70. PubMed ID: 12824579
[No Abstract] [Full Text] [Related]
5. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3.
Peters MW; Meinhold P; Glieder A; Arnold FH
J Am Chem Soc; 2003 Nov; 125(44):13442-50. PubMed ID: 14583039
[TBL] [Abstract][Full Text] [Related]
6. Analysis of NADPH supply during xylitol production by engineered Escherichia coli.
Chin JW; Khankal R; Monroe CA; Maranas CD; Cirino PC
Biotechnol Bioeng; 2009 Jan; 102(1):209-20. PubMed ID: 18698648
[TBL] [Abstract][Full Text] [Related]
7. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
[TBL] [Abstract][Full Text] [Related]
8. Improved product-per-glucose yields in P450-dependent propane biotransformations using engineered Escherichia coli.
Fasan R; Crook NC; Peters MW; Meinhold P; Buelter T; Landwehr M; Cirino PC; Arnold FH
Biotechnol Bioeng; 2011 Mar; 108(3):500-10. PubMed ID: 21246504
[TBL] [Abstract][Full Text] [Related]
9. Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium.
Urlacher VB; Schmid RD
Methods Enzymol; 2004; 388():208-24. PubMed ID: 15289074
[No Abstract] [Full Text] [Related]
10. Development of a fed-batch process for the production of the cytochrome P450 monooxygenase CYP102A1 from Bacillus megaterium in E. coli.
Pflug S; Richter SM; Urlacher VB
J Biotechnol; 2007 May; 129(3):481-8. PubMed ID: 17346843
[TBL] [Abstract][Full Text] [Related]
11. Engineering of recombinant E. coli cells co-expressing P450pyrTM monooxygenase and glucose dehydrogenase for highly regio- and stereoselective hydroxylation of alicycles with cofactor recycling.
Pham SQ; Gao P; Li Z
Biotechnol Bioeng; 2013 Feb; 110(2):363-73. PubMed ID: 22886996
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a whole-cell catalyst co-expressing glycerol dehydrogenase and glucose dehydrogenase and its application in the synthesis of L-glyceraldehyde.
Richter N; Neumann M; Liese A; Wohlgemuth R; Weckbecker A; Eggert T; Hummel W
Biotechnol Bioeng; 2010 Jul; 106(4):541-52. PubMed ID: 20198657
[TBL] [Abstract][Full Text] [Related]
13. Laboratory evolution of cytochrome p450 BM-3 monooxygenase for organic cosolvents.
Wong TS; Arnold FH; Schwaneberg U
Biotechnol Bioeng; 2004 Feb; 85(3):351-8. PubMed ID: 14748091
[TBL] [Abstract][Full Text] [Related]
14. Laboratory evolution of P450 BM3 for mediated electron transfer yielding an activity-improved and reductase-independent variant.
Nazor J; Dannenmann S; Adjei RO; Fordjour YB; Ghampson IT; Blanusa M; Roccatano D; Schwaneberg U
Protein Eng Des Sel; 2008 Jan; 21(1):29-35. PubMed ID: 18093991
[TBL] [Abstract][Full Text] [Related]
15. A continuous spectrophotometric assay for P450 BM-3, a fatty acid hydroxylating enzyme, and its mutant F87A.
Schwaneberg U; Schmidt-Dannert C; Schmitt J; Schmid RD
Anal Biochem; 1999 May; 269(2):359-66. PubMed ID: 10222011
[TBL] [Abstract][Full Text] [Related]
16. Use of kinetic isotope effects to delineate the role of phenylalanine 87 in P450(BM-3).
Rock DA; Boitano AE; Wahlstrom JL; Rock DA; Jones JP
Bioorg Chem; 2002 Apr; 30(2):107-18. PubMed ID: 12020135
[TBL] [Abstract][Full Text] [Related]
17. Optimization of fermentation conditions for P450 BM-3 monooxygenase production by hybrid design methodology.
Lu Y; Mei LH
J Zhejiang Univ Sci B; 2007 Jan; 8(1):27-32. PubMed ID: 17173359
[TBL] [Abstract][Full Text] [Related]
18. Construction of a thermostable cytochrome P450 chimera derived from self-sufficient mesophilic parents.
Eiben S; Bartelmäs H; Urlacher VB
Appl Microbiol Biotechnol; 2007 Jul; 75(5):1055-61. PubMed ID: 17468867
[TBL] [Abstract][Full Text] [Related]
19. Co-expression of P450 BM3 and glucose dehydrogenase by recombinant Escherichia coli and its application in an NADPH-dependent indigo production system.
Lu Y; Mei L
J Ind Microbiol Biotechnol; 2007 Mar; 34(3):247-53. PubMed ID: 17171348
[TBL] [Abstract][Full Text] [Related]
20. Obligatory intermolecular electron-transfer from FAD to FMN in dimeric P450BM-3.
Kitazume T; Haines DC; Estabrook RW; Chen B; Peterson JA
Biochemistry; 2007 Oct; 46(42):11892-901. PubMed ID: 17902705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
